Woodline Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Woodline Partners’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-703,500	Closed	-$29.6M	–	789
2023 Q2	$29.6M	Buy	703,500 +591,291	+527%	+$23.9M	0.35%	81
2023 Q1	$4M	Buy	+112,209	New	+$4.07M	0.05%	323
2021 Q4	–	Sell	-30,194	Closed	-$2.64M	–	824
2021 Q3	$2.64M	Sell	30,194 -78,244	-72%	-$7.08M	0.04%	370
2021 Q2	$9.7M	Buy	+108,438	New	+$9.16M	0.18%	136
2021 Q1	–	Sell	-489,893	Closed	-$33.4M	–	487
2020 Q4	$33.4M	Buy	489,893 +376,774	+333%	+$23.5M	0.89%	28
2020 Q3	$6.01M	Buy	+113,119	New	+$6.74M	0.2%	117

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Woodline Partners's SYNH Position: Q3 2023 in Review

Woodline Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 703,500 shares — an estimated $29.6M sold.

Woodline Partners first reported a position in SYNH in Q3 2020 and held it in 6 quarters. The position peaked at $33.4M in Q4 2020. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Woodline Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Woodline Partners sold 703,500 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $29.6M.
Woodline Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2020 and held it in 6 quarters.
Woodline Partners's Syneos Health, Inc. Class A Common Stock position peaked at $33.4M in Q4 2020.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Woodline Partners's 13F filing for Q3 2023, filed 14 Nov 2023.